BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 89 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,465,465 | -43.9% | 122,721 | -28.8% | 0.45% | -40.7% |
| Q2 2023 | $4,396,713 | +39.9% | 172,285 | +16.6% | 0.76% | +11.4% |
| Q1 2023 | $3,143,685 | +16.3% | 147,799 | +61.8% | 0.68% | -5.0% |
| Q4 2022 | $2,703,427 | +42.8% | 91,332 | +12.3% | 0.72% | +33.8% |
| Q3 2022 | $1,893,000 | +86.7% | 81,364 | +34.7% | 0.54% | +44.2% |
| Q2 2022 | $1,014,000 | -59.7% | 60,426 | +5.5% | 0.37% | -49.3% |
| Q1 2022 | $2,514,000 | -36.3% | 57,295 | -11.6% | 0.74% | -15.4% |
| Q4 2021 | $3,944,000 | +36.3% | 64,800 | -6.8% | 0.87% | +18.9% |
| Q3 2021 | $2,893,000 | +17.9% | 69,549 | -14.0% | 0.73% | +36.6% |
| Q2 2021 | $2,454,000 | +8.9% | 80,839 | +7.1% | 0.54% | +2.5% |
| Q1 2021 | $2,254,000 | – | 75,454 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |